CHEE CONLEY (Chief Commercial Officer) exercised options at SYROS PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 11/4/2024ACC: 0000950170-24-120866
Officer· Chief Commercial Officer
Since Sep 2021
-8.71K
Net shares
Net seller
$18.2K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
17K acquired · 25.71K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+17K
Price / share
—
Trade value
—
% of position
13.9%
10/31/2024
122.50K→139.50K
Common Stock
Direct
Shares
−8.71K
Price / share
$2.09
Trade value
$18.20K
% of position
6.2%
10/31/2024
139.50K→130.80K
Total
Net shares
+8.29K
Net value
-$18.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/31/2024 | M · Option Exercise | +17K | — | — | 13.9% | 122.50K | 139.50K |
| Common Stock Direct | 10/31/2024 | F · Tax Withholding | −8.71K | $2.09 | $18.20K | 6.2% | 139.50K | 130.80K |
| Total | +8.29K | -$18.20K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
17K shares
Shares
−17K
Strike price
Held after
0.00
Exercisable
—
10/31/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock17K shares | 10/31/2024 | M · Option Exercise | −17K | — | 0.00 |